191 related articles for article (PubMed ID: 12056538)
1. Effect of microcrystalline cellulose grade and process variables on pellets prepared by extrusion-spheronization.
Alvarez L; Concheiro A; Gómez-Amoza JL; Souto C; Martínez-Pacheco R
Drug Dev Ind Pharm; 2002 Apr; 28(4):451-6. PubMed ID: 12056538
[TBL] [Abstract][Full Text] [Related]
2. Influence of MCC II fraction and storage conditions on pellet properties.
Krueger C; Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
[TBL] [Abstract][Full Text] [Related]
3. A study of the effects of the physical characteristics of microcrystalline cellulose on performance in extrusion spheronization.
Heng PW; Koo OM
Pharm Res; 2001 Apr; 18(4):480-7. PubMed ID: 11451035
[TBL] [Abstract][Full Text] [Related]
4. Formulation and evaluation of mefenamic acid sustained release matrix pellets.
Ibrahim MA
Acta Pharm; 2013 Mar; 63(1):85-98. PubMed ID: 23482315
[TBL] [Abstract][Full Text] [Related]
5. The influence of microcrystalline cellulose grade on shape and shape distributions of pellets produced by extrusion-spheronization.
Koo OM; Heng PW
Chem Pharm Bull (Tokyo); 2001 Nov; 49(11):1383-7. PubMed ID: 11724226
[TBL] [Abstract][Full Text] [Related]
6. Analysis of particle kinematics in spheronization via particle image velocimetry.
Koester M; Thommes M
Eur J Pharm Biopharm; 2013 Feb; 83(2):307-14. PubMed ID: 23000404
[TBL] [Abstract][Full Text] [Related]
7. Extrusion/spheronization--effect of moisture content and spheronization time on pellet characteristics.
Iyer RM; Augsburger LL; Pope DG; Shah RD
Pharm Dev Technol; 1996 Dec; 1(4):325-31. PubMed ID: 9552316
[TBL] [Abstract][Full Text] [Related]
8. Starch-dextrin mixtures as base excipients for extrusion-spheronization pellets.
Almeida Prieto S; Blanco Méndez J; Otero Espinar FJ
Eur J Pharm Biopharm; 2005 Apr; 59(3):511-21. PubMed ID: 15760732
[TBL] [Abstract][Full Text] [Related]
9. Powdered cellulose as excipient for extrusion-spheronization pellets of a cohesive hydrophobic drug.
Alvarez L; Concheiro A; Gómez-Amoza JL; Souto C; Martínez-Pacheco R
Eur J Pharm Biopharm; 2003 May; 55(3):291-5. PubMed ID: 12754003
[TBL] [Abstract][Full Text] [Related]
10. Functionality of cross-linked polyvinylpyrrolidone as a spheronization aid: a promising alternative to microcrystalline cellulose.
Liew CV; Gu L; Soh JL; Heng PW
Pharm Res; 2005 Aug; 22(8):1387-98. PubMed ID: 16078149
[TBL] [Abstract][Full Text] [Related]
11. Alternative extrusion-spheronization aids.
Jain SP; Singh PP; Amin PD
Drug Dev Ind Pharm; 2010 Nov; 36(11):1364-76. PubMed ID: 20521907
[TBL] [Abstract][Full Text] [Related]
12. Control of drug release by incorporation of sorbitol or mannitol in microcrystalline-cellulose-based pellets prepared by extrusion-spheronization.
Goyanes A; Souto C; Martínez-Pacheco R
Pharm Dev Technol; 2010 Dec; 15(6):626-35. PubMed ID: 20148708
[TBL] [Abstract][Full Text] [Related]
13. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
Verheyen P; Steffens KJ; Kleinebudde P
Drug Dev Ind Pharm; 2009 Nov; 35(11):1325-32. PubMed ID: 19832632
[TBL] [Abstract][Full Text] [Related]
14. Properties of microcrystalline cellulose and powder cellulose after extrusion/spheronization as studied by fourier transform Raman spectroscopy and environmental scanning electron microscopy.
Fechner PM; Wartewig S; Füting M; Heilmann A; Neubert RH; Kleinebudde P
AAPS PharmSci; 2003 Nov; 5(4):E31. PubMed ID: 15198519
[TBL] [Abstract][Full Text] [Related]
15. The evaluation of the rheological properties of lactose/microcrystalline cellulose and water mixtures by controlled stress rheometry and the relationship to the production of spherical pellets by extrusion/spheronization.
MacRitchie KA; Newton JM; Rowe RC
Eur J Pharm Sci; 2002 Oct; 17(1-2):43-50. PubMed ID: 12356419
[TBL] [Abstract][Full Text] [Related]
16. Formulation of ranitidine pellets by extrusion-spheronization with little or no microcrystalline cellulose.
Basit AW; Newton JM; Lacey LF
Pharm Dev Technol; 1999; 4(4):499-505. PubMed ID: 10578503
[TBL] [Abstract][Full Text] [Related]
17. Insights into the functionality of pelletization aid in pelletization by extrusion-spheronization.
Sarkar S; Heng PW; Liew CV
Pharm Dev Technol; 2013 Feb; 18(1):61-72. PubMed ID: 21981607
[TBL] [Abstract][Full Text] [Related]
18. Influence of process variables on physical properties of the pellets using extruder and spheronizer.
Umprayn K; Chitropas P; Amarekajorn S
Drug Dev Ind Pharm; 1999 Jan; 25(1):45-61. PubMed ID: 10028418
[TBL] [Abstract][Full Text] [Related]
19. The evaluation of formulations for the preparation of pellets with high drug loading by extrusion/spheronization.
Podczeck F; Knight P
Pharm Dev Technol; 2006; 11(3):263-74. PubMed ID: 16895837
[TBL] [Abstract][Full Text] [Related]
20. Torque rheological parameters to predict pellet quality in extrusion-spheronization.
Soh JL; Liew CV; Heng PW
Int J Pharm; 2006 Jun; 315(1-2):99-109. PubMed ID: 16574352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
